prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, PATIENT HISTORY: PRE OP DIAGNOSIS: CALEFT BREAST. POST OP DIAGNOSIS: SAME. PROCEDURE: LEFT TOTAL MASTECTOMY, AXILLARY DISSECTION. ADDENDA: Addendum. ESTROGEN/PROGESTERONE REPORT. Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method, and reported according to the. :onsensus statement on adjuvant. therapy for breast cancer, o. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER negative. Percent cells staining as: (0 100%). PR negative. Percent cells staining as: (0 100%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). Her-2/Neu FISH was ordered. The Her-2/neu and estrogen assays were performed with FDA approved. ) methods. The progesterone receptor. immunoperoxidase test used in this case has ben- valoned and the performance characteristics determined by the. Department of Pathology at. They have not been cleared or approved by. the U>S. Food and Drug Administration. FINAL DIAGNOSIS: LEFT MODIFIED RADICAL MASTECTOMY (TOTAL) AND AXILLARY DISSECTION: PART 1: LEFT AXILLARY CONTENTS: TWO OF TWENTY-FIVE (2/25) LYMPH NODES WITH METASTATIC POORLY DIFFERENTIATED DUCTAL. CARCINOMA OF BREAST. PART 2: LEFT BREAST: A). INFILTRATING POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA, NOTTINGHAM SCORE. 8/9 (NUCLEI 3, TUBULE 2, MITOSIS 3), MEASURING 3.0 BY 2.5 BY 0.7 CM, LOCATED IN THE. LOWER OUTER AND LOWER INNER QUADRANT (CROSS REFER. B). TUMOR ASSOCIATED MICROCALCIFICATIONIS. C). ALL MARGINS FREE OF TUMOR. D). NIPPLE AND SKIN FREE OF TUMOR. E). PROLIFERATIVE FIBROCYSTIC CHANGES WITH DUCT ECTASIA, RADIAL SCAR AND. SCLEROSING ADENOSIS. COMMENT: ER/PR AND Her-2/neu will be performed on "2D" and a report will follow.

expanded version (tokens=983) : 
 Histological classification: Infiltrating poorly differentiated ductal adenocarcinoma with a Nottingham score of 8/9 (nuclei 3, tubule 2, mitosis 3).

Subtype: Basal.

Necrosis: No mention of necrosis in the report.

Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes in the report.

Histological grade: Nottingham score of 8/9 (nuclei 3, tubule 2, mitosis 3).

Nuclear grade: Not specified, but the Nottingham score indicates a nuclear grade of 3.

Lymphovascular invasion: Not mentioned in the report.

Calcification: Microcalcifications were present.

Receptor status: The report mentions that ER/PR and Her-2/neu tests will be performed separately.

IHC and ancillary testing results: The immunoperoxidase test for estrogen/progesterone receptors was positive. The Her-2/neu DAKO Herceptest showed weak to moderate complete membrane staining in more than 10% of the tumor cells, which was interpreted as weakly positive. Her-2/neu FISH was ordered. Proliferative fibrocystic changes, duct ectasia, radial scar, and sclerosing adenosis were also noted in the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1158) : 
 Left breast pathology reported infiltrating poorly differentiated basal subtype ductal adenocarcinoma with a Nottingham score of 8/9 (nuclei 3, tubule 2, mitosis 3), measuring 3.0 by 2.5 by 0.7 cm in size, located in the lower outer and lower inner quadrant with microcalcifications. ER/PR positive and HER-2/neu weakly positive; further testing ordered, and lymphovascular invasion not mentioned. Proliferative fibrocystic changes, duct ectasia, radial scar, and sclerosing adenosis noted.

